Company News

Share this article:

GlaxoSmithKline announced that it will form a joint venture with China-based Jiangsu Walvax Biotech Company to develop pediatric vaccines for measles, mumps and rubella in China. GSK is investing $29.7 million in the deal initially, and will invest an additional $10.7 million in 2015, according to a company statement.

EMD Serono Canada tapped Ariad Healthcare to market its probiotic multivitamin Multibionta – the number one selling multivitamin in France and the UK – in Canada. Other partners on the assignment include Rao Barrett & Welsh, Environics and M2 Universal.


Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.